Genetics Press Release
|11/24/2020 - 12:20||
Proteins use immune cells to cause brain disease
Controlling the number or function of immune cells could protect against deadly brain diseases, a review study concludes.
|11/18/2020 - 05:38||
Bioinformatic approaches facilitated new disease gene and genomic content discovery in dogs
A new study found causal variants in three new disease genes in dogs. Based on the results of the study, novel genetic tests for diagnostics were developed. The findings have implications also to human medicine with novel candidate genes in same rare disorders.
|11/17/2020 - 17:00||
NEOGEN, Transnetyx launch collaboration for mouse genotyping
LINCOLN, Neb., Nov. 17, 2020 — NEOGEN Corporation announced today its partnership with Transnetyx, Inc., to collaborate on distribution and advancement of the miniMUGA genotyping array (Mouse Universal Genotyping Array) through Transnetyx’s wide-reaching footprint in the model organism community.
|11/05/2020 - 07:12||
Genetic testing: Employee perk or privacy hazard?
New $3.3 million NIH-funded study will examine ethical, policy implications of workplace genomic testing.
|University of M...|
|10/23/2020 - 08:27||
Gene map to aid studies of key traits in sheep
Genetic code insights pave the way to more accurate research into traits of interest in sheep, such as health and resilience.
|10/14/2020 - 06:41||
Genome explains differences in wild and farmed salmon
Structural differences in salmon genomes affecting brain genes may explain behavioural changes between wild and domesticated populations.
|10/12/2020 - 17:01||
Illumina Pledges US $20 Million in Sequencing Tech for Africa
A dangerous novel pathogen emerging in any region is devastating, but even more so when genomics and bioinformatics infrastructure is insufficient to identify, monitor, or slow its spread. In resource-limited environments, public health officials struggle to allocate precious medical commodities such as diagnostics or vaccines. Africa needs information in real-time, and in high fidelity. Next-generation sequencing (NGS) of pathogen genomes can provide these insights, mitigating the potential loss of life.
|09/14/2020 - 20:25||
Van Andel Institute to serve as Cancer MoonshotSM Biorepository
GRAND RAPIDS, Mich. (September 15, 2020) — Van Andel Institute’s Biorepository has been awarded a $2.7 million, two-year subcontract from the Frederick National Laboratory for Cancer Research currently operated by Leidos Biomedical Research, Inc.
|09/09/2020 - 20:21||
New Genetic Analysis Method Could Advance Personal Genomics
Sept. 10, 2020 CONTACT: Doug Donovan Cell: 443-462-2947 firstname.lastname@example.org @dougdonovan.
|09/02/2020 - 11:22||
Option Care Health Selected as a Limited Distribution Provider of VILTEPSO (viltolarsen) Injection for Patients with Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
Manufactured by NS Pharma, Inc., Viltepso is the first and only exon 53 skipping therapy to demonstrate an increase in dystrophin in patients as young as four years old.
|08/19/2020 - 09:12||
New Guidelines Recommend Non-Invasive Prenatal Testing for All
New guidelines from the American College of Obstetricians and Gynecologists (ACOG) recommend Non-Invasive Prenatal Testing (NIPT) be made available to all pregnant women, regardless of maternal age or baseline risk. Previously, only pregnant women at risk or over the age of 35 were offered NIPT to learn vital information about the health of their baby, as early as week 10 of their pregnancy.
|08/17/2020 - 23:57||
Research Story Tip: Down Syndrome Mice Open Door to Better Understanding of the Genetic Disorder
Photograph of a karyotype – the collection of chromosomes within each cell of an organism – from a male mouse engineered by Johns Hopkins Medicine researchers to model Down syndrome in a human. The rodent possesses the 20 pairs of chromosomes (including the XY pair at the end that determines gender) normally seen in a mouse plus a piece of chromosome 21 from a human cell (indicated by the yellow arrow). Down syndrome occurs in humans when there is an extra partial or entire copy of the 21st chromosome. Credit: Johns Hopkins Medicine.
|Johns Hopkins H...|
|08/13/2020 - 05:17||
Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
Brains scans helped researchers discover that manipulating cancer cell metabolism may combat DIPGs and other brain tumors. Above is a scan of a DIPG patient. Venneti lab, University of Michigan Medical School.
|08/02/2020 - 21:42||
Ancestry Launches AncestryHealth Powered by Next Generation Sequencing (NGS)
Designed to help people understand their risk for developing certain inheritable health conditions, the advanced testing technology behind AncestryHealth provides more comprehensive genetic screening of an expanded set of health conditions -- such as heart disease, breast cancer, colon cancer and blood disorders. AncestryHealth powered by NGS looks at more places in a person’s DNA than microarray-based testing technology.
|07/29/2020 - 13:04||
New maps of chemical marks on DNA pinpoint regions relevant to many developmental diseases
Salk researchers mapped how DNA methylation changes over time in mice to better understand developmental disorders.
|07/27/2020 - 22:10||
UMass Amherst Biologists Zero in on Cells Environmental Sensing Mechanism
In addition to lead investigators Albertson and Rolf Karlstrom, the team includes recently graduated doctoral students Dina Navon and Ira Male, current Ph.D. candidate Emily Tetrault and undergraduate Benjamin Aaronson. Their paper appears now in Proceedings of the National Academy of Sciences .
|University of M...|
|07/23/2020 - 00:53||
Story Tip: New Johns Hopkins Center Focuses on Genetic Eye Diseases
Often, one of the biggest challenges facing patients with a genetic condition is being able to diagnose it. For patients with one of the more than 350 known genetic eye disorders, the difficulty of making a diagnosis — and as a result, choosing the appropriate treatment — can be compounded because their eye disease may occur in isolation or as part of a broader, systemic genetic problem.
|Johns Hopkins H...|
|07/20/2020 - 15:54||
City of Hope researchers identify mechanism that may lead to metabolic memory and sustained diabetes complications
DUARTE, Calif. — For people with diabetes, vascular complications like kidney disease and atherosclerosis, which can lead to poor health and even death, are seen at increased rates. In a new Nature Metabolism study , researchers led by City of Hope’s Rama Natarajan , Ph.D., the National Business Products Industry Professor in Diabetes Research, identified for the first time an underlying mechanism for metabolic memory and its involvement in the development of such complications.
|City of Hope Na...|
|07/14/2020 - 04:40||
NIH researchers generate complete human X chromosome sequence
Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, have produced the first end-to-end DNA sequence of a human chromosome.
|07/10/2020 - 01:33||
First precision mitochondrial DNA editor, social factors and COVID-19, a gene drive tuner, and more
Welcome to the July 10, 2020 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators.
|07/08/2020 - 16:53||
New Hope for Rare Disease Families
Illumina’s TruSight™ Software Suite simplifies next generation sequencing (NGS) bioinformatics and allows the user to easily prioritize and review genomic variation(s) likely to cause a rare genetic disease. By enabling laboratories and researchers to quickly annotate and navigate the billions of base pairs in a patient’s genetic code, TruSight Software Suite will make it easier to glean valuable medical insights from whole-genome sequencing data.
|07/02/2020 - 14:20||
Automating and configuring high performance clinical genomics workflows
One of the most innovative healthcare organizations (1
|06/29/2020 - 03:25||
Genomics England launches next-generation research platform central to UK COVID-19 response
British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments.
|06/19/2020 - 06:13||
Study shows how Australias burrowing frogs handle the heat
Researchers have shown how the unique genetic make-up of a group of Australian frogs could be the key to their survival, allowing them to better withstand our harsh climate.
|06/17/2020 - 03:59||
CF Foundation Invests up to $14M in Effort to Solve Key Challenges to Gene Delivery in Cystic Fibrosis
BETHESDA, Md. -- Today the Cystic Fibrosis Foundation announced an investment of up to $14 million in 4D Molecular Therapeutics (4DMT) to develop a customized vehicle to deliver a healthy cystic fibrosis transmembrane conductance regulator (CFTR) gene into the lung cells of people with cystic fibrosis (CF). The delivery of genetic-based therapies is one of the key hurdles to developing an effective therapy for the more than 1,700 different mutations that cause CF, including nonsense and rare mutations.
- 1 of 100